A chemo tester that can test the effectiveness of different agents before injection into the body could improve the effectiveness of chemotherapy.
Developed by a team from Rutgers University, the device is first seeded by a tumor biopsy, which different chemo agents are then exposed to and their effectiveness measured. A biosensor is used to count the number of live and dead cancer cells, with the data crunched by AI. The results are delivered almost instantly, and tests with the device have proven it to be more than 95 percent accurate—allowing treatment to begin as soon as the biopsy has been completed.
More Info about this Invention: